These materials are under embargo until 9th February 2017, hence their placement within the Cancer52 member area of the website. We are...

We have written a briefing entitled NICE and Patient Involvement...What's the point? because the NICE Consultation on improving how...

"Bringing patient perspectives to NICE: Help us to help you become a key voice" by Victoria Thomas (Head of Public Involvement, NICE)...

Cancer52 has responded to the above consultation (January 2017). The full response can be found here. In summary Cancer52 disagreed with...

Cancer52 has responded to the above consultation (January 2017). The full response can be found here. The consultation covers four areas...

Terms of reference, minutes of the first meeting and membership are now available for this Group, whose role is to advise and assess on...

Available from 6th December 2016 to mark the Cancer52 session at Britain Against Cancer - a new report from Cancer52 on the role of the...

We enjoyed a stimulating and informative meeting with presentations from Helen Morement of AMMF; Chris Arthur of the PRDA, Clare Soares...

On 28th July 2016 Cancer52 published its Cancer52 Position Paper on the new Cancer Drugs Fund Operating Model FINAL 28th July 2016.

On 22nd June 2016 Cancer52 published its Cancer52 position statement Cancer Implementation Plan June 2016 FINAL.